e-learning
resources
Virtual 2020
Pre-Congress Content
Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Women receiving hormone replacement therapy are at high risk of developing asthma
E. Sören Halvard Hansen (Copenhagen, Denmark), K. Aasbjerg (Aarhus, Denmark), A. Lykkemark Møller (Hillerød, Denmark), E. Gade (Slagelse, Denmark), C. Torp-Pedersen (Hillerød, Denmark), V. Backer (Copenhagen, Denmark)
Source:
Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Session:
Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Session type:
E-poster session
Number:
1430
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Sören Halvard Hansen (Copenhagen, Denmark), K. Aasbjerg (Aarhus, Denmark), A. Lykkemark Møller (Hillerød, Denmark), E. Gade (Slagelse, Denmark), C. Torp-Pedersen (Hillerød, Denmark), V. Backer (Copenhagen, Denmark). Women receiving hormone replacement therapy are at high risk of developing asthma. 1430
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Late-breaking abstract: Postmenopausal hormone replacement therapy is associated with increased risk of asthma hospitalization
Source: Annual Congress 2011 - Respiratory epidemiology: quality of life, therapy and socioeconomics
Year: 2011
The effects of hormone replacement therapy on pulmonary function in postmenopausal women
Source: Eur Respir J 2004; 24: Suppl. 48, 574s
Year: 2004
Long-term inhaled corticosteroid use in COPD and the risk of fracture in men and women
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016
Asthma and hayfever is associated with use of oral contraceptives and hormonal replacement therapy
Source: Annual Congress 2003 - Risk factors for asthma
Year: 2003
Using hormone replacement therapy in perimenopausal women with bronchial asthma (BA)
Source: Annual Congress 2007 - Novel issues in the treatment and control of asthma
Year: 2007
Low risk of adrenal dysfunction in children with severe asthma treated with high-dose inhaled glucocorticoids
Source: Eur Respir J 2005; 26: Suppl. 49, 161s
Year: 2005
Osteoporosis risk associated with chronic corticoid inhalation therapy in patients with COPD
Source: Annual Congress 2009 - Prognosis and comorbidities in COPD
Year: 2009
Hormone replacement therapy associated with improved oxygenation in women with IPF
Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease
Year: 2010
Identifying patients with severe asthma that will be benefit from biological therapy
Source: Virtual Congress 2020 – Rethinking asthma
Year: 2020
The influence of glucocorticoid therapy on the level of sex hormones in menopausal women with bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 51s
Year: 2002
Effectiveness of a cognitive orientation program with and without nicotine replacement therapy in stopping smoking in hospitalised patients
Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment
Year: 2011
Combination therapy of inhaled corticosteroids and long-acting beta
2
-agonists may be associated with risk reduction of lung cancer in COPD patients who quit smoking
Source: Eur Respir J 2006; 28: Suppl. 50, 454s
Year: 2006
Characteristics of patients treated with nicotine replacement therapy (NRT) prescribed during hospitalization
Source: International Congress 2019 – Tobacco cessation interventions in different settings and populations
Year: 2019
Effectiveness of combined therapy in patients with brittle asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 512s
Year: 2002
Does azithromycin-prednisolone combination therapy have additive effects than single therapy in patients with persistent asthma?
Source: Annual Congress 2009 - Aspects of uncontrolled asthma
Year: 2009
The effects of hormone therapy on pulmonary function tests in postmenopausal women
Source: Eur Respir J 2004; 24: Suppl. 48, 573s
Year: 2004
Combined therapy of severe osteoporosis for patients with bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 47s
Year: 2001
Osteoporosis and fracture risk associated with inhaled corticosteroid use among Swedish COPD patients: the ARCTIC study
Source: Eur Respir J, 57 (2) 2000515; 10.1183/13993003.00515-2020
Year: 2021
Effect of maintenance oral corticosteroids on risk factors for frequent exacerbations in a severe adult asthma population
Source: Virtual Congress 2020 – Severe asthma phenotypes and outcomes
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept